PMP22 Antibodies

Santa Cruz Biotechnology offers a broad range of PMP22 monoclonal antibodies for investigating PMP22 protein's role in various biological processes. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PMP22, a critical component of peripheral myelin, plays a vital role in the formation and maintenance of myelin sheaths around peripheral nerves. Mutations or dysregulation of PMP22 are associated with several neuropathies, including Charcot-Marie-Tooth disease, making PMP22 an important target for research into peripheral nerve disorders. Understanding the function and regulation of PMP22 is essential for developing therapeutic strategies for these conditions. Research into PMP22 continues to reveal new insights about its role in nerve development and disease progression. Current studies focus on understanding how PMP22 influences myelin formation and maintenance in healthy and diseased states. Ongoing investigations explore potential therapeutic approaches targeting PMP22-related pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of peripheral nerve biology and contribute to the development of new therapeutic strategies for neurological disorders.